References
- Jantharaprapap R, Stagni G. (2007). Effects of penetration enhancers on in vitro permeability of meloxicam gel. Int J Pharm, 343(1–2):26–33.
- McNeill SC, Potts RO, Francoeur ML. (1992). Local enhanced topical delivery (LETD) of drugs: Does it truly exist? Pharm Res, 9:1422–7.
- Turck D, Busch U, Heinzel G, Narjes H. (1997). Clinical pharmacokinetics of meloxicam. Arzneimittelforsch, 47(3):253–8.
- Aghazadeh-Habashi A, Jamali F. (2008). Pharmacokinetics of meloxicam administered as regular and fast dissolving formulations to the rat: Influence of gastrointestinal dysfunction on the relative bioavailability of two formulations. Eur J Pharm Biopharm, doi: 10.1016/j.ejpb. 2008.07.013.
- Luger P, Daneck K, Engel W, Trummlitz G, Wagner K. (1996). Structure and physicochemical properties of meloxicam, a new NSAID. Eur J Pharm Sci, 4:175–87.
- Mazzenga GC, Berner B. (1991). The transdermal delivery of zwitterionic drugs. I: The solubility of zwitterion salts. J Control Release, 16:77–88.
- Hatanaka T, Kamon T, Morigaki S, Katayama K, Koizumi T. (2000). Ion pair skin transport of a zwitterionic drug, cephalexin. J Control Release, 66(1):63–71.
- Megwa SA, Cross SE, Benson HAE, Roberts MS. (2000). Ion-pair formation as a strategy to enhance topical delivery of salicylic acid. J Pharm Pharmacol, 52:919–28.
- Ki HM, Choi HK. (2007). The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam. Arch Pharm Res, 30(2):215–21.
- Chang JS, Huang YB, Hou SS, Wang RJ, Wu PC, Tsai YH. (2007). Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm, 338:48–54.
- Sawada H, Kawakami J. (2006). Influence of combinations of enhancers on skin permeation of meloxicam. Drug Delivery Syst, 21(5):537–44.
- Yuan Y, Li SM, Mo FK, Zhong DF. (2006). Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm, 321:117–23.
- Ren C, Fang L, Li T, Wang M, Zhao L, He Z. (2008). Effect of permeation enhancers and organic acids on the skin permeation of indapamide. Int J Pharm, 350(1–2):43–7.
- Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y. (2002). The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull, 25(10):1339–44.
- McDaid DM, Deasy PB. (1996). Formulation development of a transdermal drug delivery system for amlodipine base. Int J Pharm, 133:71–83.
- Wang M, Fang L, Ren C, Li T. (2008). Effect of ion-pairing and enhancers on scutellarin skin permeability. J Pharm Pharmacol, 60:429–35.
- Fini A, Fazio G, Gonzalez-Rodriguez M, Cavallari C, Passerini N, Rodriguez L. (1999). Formation of ion-pairs in aqueous solutions of diclofenac salts. Int J Pharm, 187:163–73.
- Fang L, Numajiri S, Kobayashi D, Morimoto Y. (2003). The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int J Pharm, 262:13–22.
- Jiang Y, Fang L, Niu X, Rui M, He Z. (2008). The effect of ion pairing on the skin permeation of amlodipine. Pharmazie, 63(5):356–60.
- Sawa CL, Heng PW, Chin WW, Soo KC, Olivo M. (2006). Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. Cancer Lett, 238:104–10.
- Lee PJ, Ahmad N, Langer R, Mitragotri S, Prasad SV. (2006). Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm, 308:33–9.
- Williams AC, Barry BW (2004). Penetration enhancers. Adv Drug Deliv Rev, 56:603–18.